심방 중격 결손증 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 수술 전후 치료를위한 원격 의료 사용 증가, 유전 및 표현형 데이터를 기반으로 한 개인화 된 치료 계획의 성장, 특히 신흥 시장에서 글로벌 의료 지출의 지속적인 증가, 노인 인구 증가로 인한 선천성 심장 결함의 후기 진단 발생률 증가, 글로벌 시장 침투를 개선하는 의료 기기 규정의 국제 조화, 선천성 심장 질환의 조기 발견 및 치료를 목표로하는 국내 및 국제 보건 프로그램의 구현에 기인 할 수 있습니다. 예측 기간의 주요 트렌드에는 새로운 최소 침습적 ASD 폐쇄 장치 개발, 진단 개선 및 개인 맞춤형 치료 계획을 위한 AI 및 머신러닝 사용, 장치 제조를 위한 생분해성 및 생체 흡수성 재료 도입, ASD 시술 중 실시간 모니터링 및 의사 결정 지원을 위한 AI 기반 도구, 환자 회복 추적 및 합병증 조기 발견을 위한 원격 모니터링 기술 채택 등이 있습니다.
심방 중격 결손증 시장은 선천성 심장 질환(CHD)의 유병률 증가로 성장이 예상됩니다. 방 사이의 비정상적인 혈류를 수정하고 심장 기능을 개선하고 관련 합병증을 줄임으로써 CHD를 관리하는 데 매우 중요합니다. 예를 들어, 2024년 6월 호주 보건 복지 연구소의 데이터에 따르면 호주에서는 어린이와 성인을 포함해 약 6만 5,000명이 선천성 심장 질환을 앓은 것으로 나타났습니다. 선천성 심장병과 관련된 입원은 2020-2021년 동안 약 5,900건이었으며, 1세 미만 영아에서 79명이 사망하여 전체 영아 사망의 7.8%를 차지했습니다. 이 데이터는 심방 중격 결손증 시장의 성장의 원동력을 뒷받침하고 있습니다.
심방 중격 결손증 시장의 주요 기업은 첨단 장치 개발 및 승인 획득에 주력하고 있으며, 가용성과 용도를 확대하고 있습니다. 예를 들어, 2024년 3월 Occlutech GmbH는 심방중격결손증(ASD) 치료를 위한 Occlutech ASD Occluder 및 Occlutech Pistol Pusher가 FDA의 승인을 받았다고 발표했습니다. Braun Interventional Systems와의 독점적 파트너십을 통해 미국에서 제품화가 가능해졌으며, 자체 확장형 니티놀제 디바이스인 오클루텍 ASD 오클루더는 결함이 확인된 환자에게 평생 솔루션을 제공하여 세계적으로 건강을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 심방 중격 결손증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 심방 중격 결손증 시장 : 성장률 분석
- 세계의 심방 중격 결손증 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 심방 중격 결손증 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 심방 중격 결손증 전체 시장(TAM)
제6장 시장 세분화
- 세계의 심방 중격 결손증 시장 : 치료 절차별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 수술적 폐쇄
- 경 카테터 폐쇄
- 하이브리드 수술
- 약물요법
- 세계의 심방 중격 결손증 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 흉부 X선
- 심전도
- 심장 카테터 삽입
- 경식도 심초음파
- 맥박 산소 측정기
- 세계의 심방 중격 결손증 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 의료기기
- 의약품
- 세계의 심방 중격 결손증 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 소아
- 성인
- 세계의 심방 중격 결손증 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 외래수술센터(ASC)
- 심장 클리닉
- 기타 최종 사용자
- 세계의 심방 중격 결손증 시장 : 수술적 폐쇄 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 개심술(전통적인 외과적 폐쇄술)
- 최소 침습적 외과적 폐쇄술
- ASD 폐쇄용 패치(심낭, 합성)
- 세계의 심방 중격 결손증 시장 : 경 카테터 폐쇄 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 장치 기반 폐쇄(앰플라처 중격 폐쇄기)
- 경카테터 플러그 폐쇄 기법
- 성인 및 소아 환자를 위한 카테터 기반 ASD 수리
- 세계의 심방 중격 결손증 시장 : 하이브리드 수술 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 수술 및 트랜스카테터 기술의 조합
- 최소 침습 하이브리드 수술
- 복잡하거나 큰 Asds용 하이브리드 폐쇄술
- 세계의 심방 중격 결손증 시장 : 약물요법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 항응고제 치료(뇌졸중 예방)
- 이뇨제(증상 관리용)
- 항고혈압제(관련 질환 관리용)
- 기타 약물의 오프라벨 사용
제7장 지역별/국가별 분석
- 세계의 심방 중격 결손증 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 심방 중격 결손증 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 심방 중격 결손증 시장 : 경쟁 구도
- 심방 중격 결손증 시장 : 기업 프로파일
- Abbott Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
- Medtronic plc 개요, 제품 및 서비스, 전략 및 재무 분석
- Siemens Healthineers 개요, 제품 및 서비스, 전략 및 재무 분석
- Boston Scientific Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- Philips Healthcare 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Edwards Lifesciences Corporation
- WL Gore & Associates Inc.
- St. Jude Medical LLC
- Cook Medical
- Lepu Medical Technology Co. Ltd.
- MicroPort Scientific Corporation
- Lifetech Scientific Corporation
- Venus Medtech Hangzhou Inc
- Occlutech Holding AG
- Coherex Medical
- Osypka AG
- Arjo AB
- Heart Medical Europe BV
- AtriCure Inc.
- Asklepion Pharmaceuticals LLC
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 심방 중격 결손증 시장(2029년) : 새로운 기회를 제공하는 국가
- 심방 중격 결손증 시장(2029년) : 새로운 기회를 제공하는 부문
- 심방 중격 결손증 시장(2029년) : 성장 전략
제36장 부록
KTH
An atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, leading to increased blood flow to the lungs and potential complications such as pulmonary hypertension and heart failure over time.
The main treatment options for atrial septal defects include surgical closure, transcatheter closure, hybrid procedures, and medication therapy. Surgical closure involves repairing or sealing the abnormal opening through surgical intervention. Diagnostic techniques used for ASD include chest x-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry. These diagnostics are facilitated by medical devices and pharmaceutical products and are utilized in pediatric and adult patients across various healthcare settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.
The arterial septal defect research report is one of a series of new reports from The Business Research Company that provides arterial septal defect market statistics, including the arterial septal defect industry's global market size, regional shares, competitors with an arterial septal defect market share, detailed arterial septal defect market segments, market trends and opportunities, and any further data you may need to thrive in the arterial septal defect industry. This arterial septal defect market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The atrial septal defect market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities.
The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early.
The atrial septal defect market is anticipated to grow due to the rising prevalence of congenital heart defects (CHD). These defects are structural abnormalities in the heart that exist from birth. Treating atrial septal defects is crucial for managing CHD by correcting abnormal blood flow between the heart's chambers, improving heart function, and reducing associated complications. For example, data from the Australian Institute of Health and Welfare in June 2024 revealed that around 65,000 individuals in Australia, including children and adults, live with congenital heart disease. Hospitalizations related to congenital heart disease accounted for about 5,900 cases in the 2020-21 period, with 79 deaths occurring in infants under one year old, representing 7.8% of all infant deaths. This data underscores the driving force behind the atrial septal defect market's growth.
Key players in the arterial septal defect market are focusing on developing advanced devices and obtaining approvals to expand their availability and applications. Device approval is essential for gaining official authorization or certification from regulatory bodies before manufacturing, selling, or using a device in specific markets or purposes. For instance, in March 2024, Occlutech GmbH announced the FDA's approval of their Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This milestone approval allows Occlutech to commercialize their devices in the US through an exclusive partnership with B. Braun Interventional Systems. The Occlutech ASD Occluder, a self-expanding nitinol device, offers a lifelong solution for patients with confirmed defects, enhancing healthcare globally.
In February 2022, Boston Scientific Corporation acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition expands Boston Scientific's product portfolios in electrophysiology and structural heart interventions with Baylis Medical's transseptal platforms, guidewires, and left heart access tools, including the VersaCross RF Wire designed for creating atrial septal defects.
Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC
North America was the largest region in the atrial septal defect market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the atrial septal defect market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Atrial Septal Defect Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on atrial septal defect market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for atrial septal defect ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atrial septal defect market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Procedure: Surgical Closure; Transcatheter Closure; Hybrid Procedures; Medication Therapy
- 2) By Diagnosis: Chest X-Ray; Electrocardiogram; Cardiac Catheterization; Transesophageal Echocardiography; Pulse Oximetry
- 3) By Product Type: Medical Devices; Pharmaceutical Products
- 4) By Age Group: Pediatric; Adult
- 5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users
- Subsegments:
- 1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure); Minimally Invasive Surgical Closure; Patches (Pericardial, Synthetic) For Asd Closure
- 2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder); Transcatheter Plug Closure Techniques; Catheter-Based Asd Repair For Adult And Pediatric Patients
- 3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques; Minimally Invasive Hybrid Procedures; Hybrid Closure For Complex Or Large Asds
- 4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke); Diuretics (For Managing Symptoms); Antihypertensive Drugs (For Managing Associated Conditions); Off-Label Use Of Other Medications
- Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers; Boston Scientific Corporation; Philips Healthcare
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Atrial Septal Defect Market Characteristics
3. Atrial Septal Defect Market Trends And Strategies
4. Atrial Septal Defect Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Atrial Septal Defect Growth Analysis And Strategic Analysis Framework
- 5.1. Global Atrial Septal Defect PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Atrial Septal Defect Market Growth Rate Analysis
- 5.4. Global Atrial Septal Defect Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Atrial Septal Defect Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Atrial Septal Defect Total Addressable Market (TAM)
6. Atrial Septal Defect Market Segmentation
- 6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Surgical Closure
- Transcatheter Closure
- Hybrid Procedures
- Medication Therapy
- 6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chest X-Ray
- Electrocardiogram
- Cardiac Catheterization
- Transesophageal Echocardiography
- Pulse Oximetry
- 6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medical Devices
- Pharmaceutical Products
- 6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- 6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Clinics
- Other End-Users
- 6.6. Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Open Heart Surgery (Traditional Surgical Closure)
- Minimally Invasive Surgical Closure
- Patches (Pericardial, Synthetic) For Asd Closure
- 6.7. Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Device-Based Closure (Amplatzer Septal Occluder)
- Transcatheter Plug Closure Techniques
- Catheter-Based Asd Repair For Adult And Pediatric Patients
- 6.8. Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Of Surgical And Transcatheter Techniques
- Minimally Invasive Hybrid Procedures
- Hybrid Closure For Complex Or Large Asds
- 6.9. Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anticoagulant Therapy (To Prevent Stroke)
- Diuretics (For Managing Symptoms)
- Antihypertensive Drugs (For Managing Associated Conditions)
- Off-Label Use Of Other Medications
7. Atrial Septal Defect Market Regional And Country Analysis
- 7.1. Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Atrial Septal Defect Market
- 8.1. Asia-Pacific Atrial Septal Defect Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Atrial Septal Defect Market
- 9.1. China Atrial Septal Defect Market Overview
- 9.2. China Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Atrial Septal Defect Market
- 10.1. India Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Atrial Septal Defect Market
- 11.1. Japan Atrial Septal Defect Market Overview
- 11.2. Japan Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Atrial Septal Defect Market
- 12.1. Australia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Atrial Septal Defect Market
- 13.1. Indonesia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Atrial Septal Defect Market
- 14.1. South Korea Atrial Septal Defect Market Overview
- 14.2. South Korea Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Atrial Septal Defect Market
- 15.1. Western Europe Atrial Septal Defect Market Overview
- 15.2. Western Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Atrial Septal Defect Market
- 16.1. UK Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Atrial Septal Defect Market
- 17.1. Germany Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Atrial Septal Defect Market
- 18.1. France Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Atrial Septal Defect Market
- 19.1. Italy Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Atrial Septal Defect Market
- 20.1. Spain Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Atrial Septal Defect Market
- 21.1. Eastern Europe Atrial Septal Defect Market Overview
- 21.2. Eastern Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Atrial Septal Defect Market
- 22.1. Russia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Atrial Septal Defect Market
- 23.1. North America Atrial Septal Defect Market Overview
- 23.2. North America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Atrial Septal Defect Market
- 24.1. USA Atrial Septal Defect Market Overview
- 24.2. USA Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Atrial Septal Defect Market
- 25.1. Canada Atrial Septal Defect Market Overview
- 25.2. Canada Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Atrial Septal Defect Market
- 26.1. South America Atrial Septal Defect Market Overview
- 26.2. South America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Atrial Septal Defect Market
- 27.1. Brazil Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Atrial Septal Defect Market
- 28.1. Middle East Atrial Septal Defect Market Overview
- 28.2. Middle East Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Atrial Septal Defect Market
- 29.1. Africa Atrial Septal Defect Market Overview
- 29.2. Africa Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Atrial Septal Defect Market Competitive Landscape And Company Profiles
- 30.1. Atrial Septal Defect Market Competitive Landscape
- 30.2. Atrial Septal Defect Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
31. Atrial Septal Defect Market Other Major And Innovative Companies
- 31.1. Edwards Lifesciences Corporation
- 31.2. W. L. Gore & Associates Inc.
- 31.3. St. Jude Medical LLC
- 31.4. Cook Medical
- 31.5. Lepu Medical Technology Co. Ltd.
- 31.6. MicroPort Scientific Corporation
- 31.7. Lifetech Scientific Corporation
- 31.8. Venus Medtech Hangzhou Inc
- 31.9. Occlutech Holding AG
- 31.10. Coherex Medical
- 31.11. Osypka AG
- 31.12. Arjo AB
- 31.13. Heart Medical Europe BV
- 31.14. AtriCure Inc.
- 31.15. Asklepion Pharmaceuticals LLC
32. Global Atrial Septal Defect Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Atrial Septal Defect Market
34. Recent Developments In The Atrial Septal Defect Market
35. Atrial Septal Defect Market High Potential Countries, Segments and Strategies
- 35.1 Atrial Septal Defect Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Atrial Septal Defect Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Atrial Septal Defect Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
